Intravitreal triamcinolone in diabetic retinopathy

Current Diabetes Reviews

Volumn 5, Issue 1, 2009, Pages 18-25

  Abraldes, Maximo J ^a   Fernández, Maribel ^a   Gómez Ulla, Francisco ^a  

^a HOSPITAL DE L ESPERANÇA   (Spain)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Intravitreal triamcinolone; Vitrectomy

Indexed keywords

KENACORT 40; PLACEBO; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; CATARACT; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOPHTHALMITIS; HERPES SIMPLEX KERATITIS; HUMAN; HYPOPYON; INTRAOCULAR HYPERTENSION; LASER COAGULATION; NEOVASCULAR GLAUCOMA; OFF LABEL DRUG USE; PRIORITY JOURNAL; PSEUDOENDOPHTHALMITIS; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA NEOVASCULARIZATION; REVIEW; SUBCAPSULAR CATARACT; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; RETINA FOVEA; RETINA MACULA EDEMA; VITREOUS BODY;

ANTI-INFLAMMATORY AGENTS; DIABETIC RETINOPATHY; FOVEA CENTRALIS; HUMANS; MACULAR EDEMA; MODELS, MOLECULAR; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 65549097099     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909787314185     Document Type: Review

References (71)

1. Ramezani A, Tabatabaie H, Ahmadieh H. Diabetic macular edema before and after intravitreal triamcinolone injection. Korean J Ophthalmol 2007; 21: 95-9.
2. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 12: 1796-06.
3. Yam JC, Kwok AK. Update on the treatment of diabetic retinopathy. Hong Kong Med J 2007; 13: 46-60.
4. Ciardella AP, Klancnik J, Schihh W, Barile G, Chang S. Intravitreal traimcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004; 88: 1131-36.
5. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 1: 57-61.
6. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 5: 920-27.
7. Sutter FKP, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment. Three-month efficacy and safety results of a prospective, randomized, doubled-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111: 2044-9.
8. Machemer R, Sugita G, Tano Y: Treatment of intraocular proliferation with intravitreal steroids. Tr Am Ophth Soc 1979; 77: 177-8.
9. Peyman GA, Cheema R, Conway MD, et al. Triamcinolone acetonide as an aid to visualization of the vitreous and posterior hyaloid during pars plana vitrectomy. Retina 2000; 20: 554-5.
10. Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol 2007; 52: 503-22.
11. Domínguez A, Quiroga P, Jareño M. El tratamiento de enfermedades médicas con triamcinolona intravítrea. Arch Soc Esp Oftalmol 1993; 65: 491-8.
12. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980; 6: 810-16.
13. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985; 5: 708-11.
14. Ciulla TA, Criswell MH, Danis RP, et al. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants. Br J Ophthalmol 2003; 8: 1032-7.
15. Ciulla TA, Criswell MH, Danis RP, Hill TE. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001; 3: 399-04.
16. Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal. neovascularization. Graefes Arch Clin Exp Ophthalmol 1993; 1: 34-40.
17. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996; 12: 2099-104.
18. Gómez-Ulla F, Marticorena J, Alfaro V, Fernández M, Rodríguez E, Rothen M. Intravitreal triamcinolone in the treatment for diabetic macular edema. Curr Diabetes Rev 2006; 1: 99-112.
19. Doukas J, Hechtinan HB, Shepro D. Endothelial-secret arachinodic metabolites modulate polymorphonucear leukocyte chemotaxis and diapedesis in vitro. Blood 1988; 71: 771-9.
20. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-7.
21. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003; 4: 462-8.
22. Garcia-Arumi J, Boixadera A, Giralt J, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 2005; 89: 1112-4.
23. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131: 468-71.
24. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-7.
25. Gomez-Ulla F, Marticorena J, Alfaro V, Fernández MI, Abraldes M. Triamcinolona intravítrea y edema macular diabético. In: Alfaro V, Gómez-Ulla F, Quiroz-Mercado H, Figueroa MS, Villalva SJ, Eds. Retinopatía Diabética. Tratado médico quirúrgico. Mac Line, S.L; 2006; 179-98.
26. Degenring RF, Kreissig I, Jonas JB. Intraocular triamcinolone for difusse diabetic macular edema. Ophthalmologe 2004; 10: 113-20.
27. Ozkiris A, Evereklioglu C, Erkiliç K, Tamçelik N, Mirza E. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 2004; 14: 543-9.
28. Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 2004; 138: 158-60.
29. Jonas JB and Degenring RF. Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema. Klin Monatsbl Augenheilkd 2002; 219: 429-32.
30. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004; 2: 218-24.
31. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006; 113: 1533-8.
32. Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH. Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study. J Ocul Pharmacol Ther 2006; 22: 200-7.
33. Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology. 2006; 113: 800-4.
34. Gillies MC, Islam FM, Zhu M, Larsson J, Wong TY. Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. Br J Ophthalmol 2007; 9: 1323-6.
35. Lam DS, Chan CK, Mohamed S, et al. A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.Br J Ophthalmol 2007; 9: 199-203.
36. Chan CK, Mohamed S, Shanmugam MP, Tsang CW, Lai TY, Lam DS. Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol 2006; 90: 1137-41.
37. Desatnik H, Habot-Wilner Z, Alhalel A, Moroz I, Glovinsky J, Moisseiev J. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema. Isr Med Assoc J 2006; 8: 383-7.
38. Jonas JB, Kreissig I, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 2004; 138: 158-60.
39. Micelli Ferrari T, Sborgia L, Furino C, et al. Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema. Eur J Ophthalmol 2004; 14: 321-4.
40. Lubczyńska A, Kociecki J. Intravitreal triamcinolone acetonide injections in treatment of cystoid macular edema due to diabetic maculopathy. Klin Oczna 2007; 109: 165-8.
41. Zacks DN, Johnson MW. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy. Retina 2005; 25: 135-40.
42. Bandello F, Polito A, Pognuz DR, Monaco P, Dimastrogiovanni A, Paissios J.Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol 2006; 124: 643-50.
43. Zein WM, Noureddin BN, Jurdi FA, Schakal A, Bashshur ZF. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Retina 2006; 26: 137-42.
44. Choi KS, Chung JK, Lim SH. Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema. Korean J Ophthalmol 2007; 21: 11-7.
45. Yamamoto T, Hitani K, Sato Y, Yamashita H, Takeuchi S. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica 2005; 219: 206-13.
46. Higuchi A, Ogata N, Jo N, Wada M, Matsumura M. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Jpn J Ophthalmol 2006; 50: 529-31.
47. Mochizuki Y, Hata Y, Enaida H, et al. Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 2006; 26: 143-8.
48. Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 2005; 243: 20-5.
49. Jonas JB, Söfker A, Degenring R. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy? Eur J Ophthalmol 2003; 13: 468-73.
50. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 3: 244-50.
51. Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 2004; 2: 218-22.
52. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003; 5: 667-73.
53. Ranson NT, Danis RP, Ciulla TA, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol 2002; 5: 527-9.
54. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 8: 1517-25.
55. Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2004; 3: 344-7.
56. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 3: 419-25.
57. Kaushik S, Gupta V, Gupta A, Dogra MR, Singh R. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 2004; 4: 758-60.
58. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003; 2: 384-6.
59. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 2004; 3: 336-40.
60. Selim Kocabora M, Kucuksahin H, Gulkilik G, Taskapili M, Yilmazli C, Engin G. Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes. J Fr Ophtalmol 2007; 30: 32-8.
61. Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 2005; 112: 139-43.
62. Baath J, Ells AL, Crichton A, Kherani A, Williams RG. Safety profile of intravitreal triamcinolone acetonide. J Ocul Pharmacol Ther 2007; 23: 304-10.
63. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 5: 791-6.
64. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003; 5: 686-91.
65. Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol 2007; 27: 307-12.
66. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003; 8: 972-4.
67. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 9: 1279-82.
68. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW. Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 2003; 2: 271-3.
69. Jonas JB, Kreissig I, Degenring RF. Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 2003; 11: 1663-4.
70. Gulkilik G, Demirci G, Ozdamar AM, Muftuoglu GI. A case of herpetic keratitis after intravitreal triamcinolone injection. Cornea 2007; 26: 1000-1.
71. Lecleire-Collet A, Offret O, Gaucher D, Audren F, Haouchine B, Massin P. Full thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections. Acta Ophthalmol Scand 2007; 85: 795-8.